First for those that don't know,
xiaflex is marketed in Europe (and some other countries) by Pfizer under the trade name: Xiapex.Like
xiaflex in the US, xiapex is an approved therapy for Dupuytren's contracture in the european union.
Now somehow Pfizer "screwed up" in february, by presenting insuficciant studies to the German Institute for Quality and Efficiency in Health Care:
(see article:
http://www.thepharmaletter.com/file/111027/germanys-iqwig-finds-no-added-benefit-for-pfizers-xiapex.html)
Result:
In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether US drugs behemoth Pfizer’s (NYSE: PFE) Xiapex (collagenase extracted from Clostridium histolyticum) offers an added benefit in comparison with conventional regimens for the treatment of Dupuytren’s contracture.
However, such an added benefit cannot be inferred from the dossier, as the drug manufacturer presented either no data or unsuitable data on the drug, which is approved in Europe for this condition (The Pharma Letter March 31, 2011), the review body concluded.
Ok, that means that Xiapex will in future not be covered by med insurance in Germany. (I thought: big deal, i'll pay for it and I dont live there, I'm in Austria, maybe it will be a different situation). Actually it only means that Pfizer has to renegociate pricing with med insurance companies. But i also read, date from may 16 2012, that Pfizer refuses to do so:
Pfizer takes Xiapex from the market which means Xiapex (=
Xiaflex) is no longer available on the german market since may 16th.
here the article from the german pharmacy journal:
http://www.apotheke-adhoc.de/nachrichten/markt/pfizer-nimmt-xiapex-vom-markt(now this article is in german only, in quote a rough english translation of the main info)
Berlin -
After Boehringer Ingelheim and Eli Lilly have withdrawn Trajenta (Linagliptin) from the market, Pfizer is taking it's first drug from the market. Starting this wednesday the sales of Xiapex are stopped in Germany because Pfizer refuses to renegociate pricing with the Health Insurance associations.
The medication ist taken completely off the german Market. Pfizer has notified wholesalers and pharmacists it is taking back any stocks.
OK this is for
Dupuytren’s contracture only.
But in the US, once
xiaflex is approved for Peyronies Disease, it will be easy to be purchased. As a doctor will only have to prescribe it and inject it. It is already available!!!
In Germany, it will not be on the market. Additionally Pfizer will have to prove it has an added benefit to surgery. (special targetted studies etc.) And it will not be reintroduced to the market that easily.
So probably here we will have to wait much much longer for it for Peyronies Disease. And it will probably never be even partially covered by med insurance

. And as austrian market always follows german market, i am also concerned.
Luc